Stock Analysis on Net

Amgen Inc. (NASDAQ:AMGN)

$24.99

Cash Flow Statement
Quarterly Data

The cash flow statement provides information about a company cash receipts and cash payments during an accounting period, showing how these cash flows link the ending cash balance to the beginning balance shown on the company balance sheet.

The cash flow statement consists of three parts: cash flows provided by (used in) operating activities, cash flows provided by (used in) investing activities, and cash flows provided by (used in) financing activities.

Amgen Inc., consolidated cash flow statement (quarterly data)

US$ in millions

Microsoft Excel
3 months ended: Dec 31, 2025 Sep 30, 2025 Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net income (loss)
Depreciation, amortization and other
Impairment of intangible assets
Stock-based compensation expense
Deferred income taxes
Acquired in-process research and development
Loss on divestiture
(Gains) losses on equity securities
Other items, net
Noncash adjustments to reconcile net income (loss) to net cash provided by operating activities
Trade receivables, net
Inventories
Other assets
Accounts payable
Accrued income taxes, net
Long-term tax liabilities
Accrued liabilities
Accrued sales incentives and allowance
Other liabilities
Changes in operating assets and liabilities, net of acquisitions
Net cash provided by operating activities
Purchases of marketable securities
Proceeds from sales of marketable securities
Proceeds from maturities of marketable securities
Purchases of property, plant and equipment
Cash paid for acquisitions, net of cash acquired
Other
Net cash (used in) provided by investing activities
Net proceeds from issuance of debt
Extinguishment of debt
Repayment of debt
Repurchases of common stock
Dividends paid
Other
Net cash provided by (used in) financing activities
Increase (decrease) in cash and cash equivalents

Based on: 10-K (reporting date: 2025-12-31), 10-Q (reporting date: 2025-09-30), 10-Q (reporting date: 2025-06-30), 10-Q (reporting date: 2025-03-31), 10-K (reporting date: 2024-12-31), 10-Q (reporting date: 2024-09-30), 10-Q (reporting date: 2024-06-30), 10-Q (reporting date: 2024-03-31), 10-K (reporting date: 2023-12-31), 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31), 10-K (reporting date: 2021-12-31), 10-Q (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31).


The financial statement information reveals fluctuating cash flows over the observed period, spanning from March 2021 to December 2025. Operating activities generally provide a net cash inflow, though with significant variability. Investing activities are often cash-consuming, while financing activities demonstrate substantial shifts between cash inflows and outflows, largely driven by debt and equity transactions.

Net Income and Noncash Adjustments
Net income exhibits considerable fluctuation, ranging from a loss of US$113 million in December 2023 to a high of US$2,841 million in March 2023. Noncash adjustments to net income consistently contribute a positive cash flow impact, generally exceeding the magnitude of net income itself, particularly in earlier periods. However, this positive impact diminished in later periods, notably in December 2025.
Operating Activities
Net cash provided by operating activities generally remains positive throughout the period, peaking at US$4,684 million in September 2025. However, there are notable quarterly variations. A significant decrease is observed in December 2023, resulting in a cash inflow of only US$538 million. Changes in operating assets and liabilities contribute significantly to these fluctuations, with substantial impacts from trade receivables, accrued income taxes, and accrued liabilities. Specifically, large swings in accrued income taxes are apparent.
Investing Activities
Investing activities consistently represent a net cash outflow, primarily due to purchases of marketable securities and property, plant, and equipment. A particularly large outflow occurred in December 2023, primarily attributed to cash paid for acquisitions, totaling nearly US$27 billion. Proceeds from maturities of marketable securities provide partial offsets to these outflows, but are not consistently sufficient to reverse the net cash outflow.
Financing Activities
Financing activities demonstrate the most volatility. Significant net cash inflows are observed in certain periods, notably in March 2023 (US$21,509 million), driven by net proceeds from the issuance of debt. Conversely, substantial net cash outflows occur in other periods, largely due to repurchases of common stock and repayment of debt. Dividend payments also consistently represent a cash outflow. The pattern suggests active management of the capital structure through debt and equity markets.
Specific Items of Note
An acquired in-process research and development expense of US$1,505 million occurred in June 2021. A loss on divestiture of US$560 million was recorded in June 2022, and a larger loss of US$3,839 million in December 2022. Gains and losses on equity securities are also prominent, with a substantial loss of US$1,830 million in March 2023 and a loss of US$1,295 million in March 2025. Impairment of intangible assets and stock-based compensation expense also contribute to the overall cash flow picture, with the impairment charge appearing in March 2024.

Overall, the cash flow statement reflects a company actively engaged in investment, financing, and operational activities. The significant fluctuations observed across all three activity categories suggest a dynamic financial environment and strategic decision-making regarding capital allocation and funding.